Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome

Recruiting Observational Study
Liver Cirrhosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
University Hospital, Bonn · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * liver cirrhosis of any etiology * CT scan available Exclusion Criteria: * HCC or any malignant disease
Contacts

Michael Praktiknjo, MD

+49228 287 15770

michael.praktiknjo@ukbonn.de

CONTACT

Johannes Chang, MD

+49228 287 15770

johannes.chang@ukbonn.de

CONTACT